Sun XG, Li YX, Ji LF, Xu JL, Chen WX, Wang RY. Outcomes of seromuscular bladder augmentation compared with standard bladder augmentation in the treatment of children with neurogenic bladder. World J Clin Cases 2022; 10(23): 8115-8123 [PMID: 36159545 DOI: 10.12998/wjcc.v10.i23.8115]
Corresponding Author of This Article
Ruo-Yi Wang, MD, Professor, Department of Pediatric Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, No. 247 Beiyuan, Jinan 250033, Shandong Province, China. sxg17660082198@163.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 16, 2022; 10(23): 8115-8123 Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8115
Table 1 Demographic characteristics of the patients and concomitant surgery in the 2 groups, n (%)
Total patients
Sex (male/female)
Age at surgery (yr)
Follow-up duration (mo)
Ureteral reimplantation
Continent catheterizable channel
SC
46
21/25
10.6
36
32 (70.0)
19 (41.3)
SMBA
21
8/13
7.6
29.7
18 (85.7)
2 (9.5)
Table 2 Urodynamic parameters of the patients in the 2 groups before and after surgery
Pre capacity (mL)
Post capacity (mL)
Pre compliance (mL/cm H2O)
Post compliance (mL/cm H2O)
Pre pressure (cm H2O)
Post pressure (cm H2O)
SC
173.9
387.0
4.8
26.7
44.9
20.7
SMBA
151.7
200.4
3.5
6.0
50.2
34.3
P value
0.26
0.000
0.19
0.000
0.28
0.000
Table 3 Incontinence, number of clean intermittent catheterizations and oral anticholinergic drugs in the 2 groups, n (%)
Pre incontinence
Post incontinence
Number of CICs
Oral anticholinergic drugs
SC
32 (69.6)
3 (6.5)
5.6
8 (17.4)
SMBA
18 (85.7)
7 (33.3)
7.6
17 (81.0)
P value
0.229
0.008
0.000
0.000
Table 4 Postoperative complications in the 2 groups, n (%)
Intestinal obstruction
Leakage
Incision infection
Recurrent UTIs
Bladder calculi
Residual reflux
Reaugmentation
SC
2 (4.3)
4 (8.7)
6 (13.0)
4 (8.7)
3 (6.5)
1 (2)
0
SMBA
1 (4.8)
5 (23.8)
6 (28.6)
2 (9.5)
1 (4.8)
7 (33.3)
6 (28.6)
Citation: Sun XG, Li YX, Ji LF, Xu JL, Chen WX, Wang RY. Outcomes of seromuscular bladder augmentation compared with standard bladder augmentation in the treatment of children with neurogenic bladder. World J Clin Cases 2022; 10(23): 8115-8123